Recurrent Extensive Stage Lung Small Cell Carcinoma
2 clinical trials · Condition
◉ Watch Recurrent Extensive Stage Lung Small Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer (NCT05353439) | National Cancer Institute (NCI) | 2022-07-27 |
| Durvalumab and Lurbinectedin for the Treatment of Relapsed or Refractory Small Cell Lung Cancer (NCT04607954) | Mayo Clinic | 2020-12-04 |
Track Recurrent Extensive Stage Lung Small Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.